Merck Signs Definitive Agreement to Acquire Mirus Bio, Furth

Mirus Bio's transfection reagents strengthen Merck's upstream portfolio Acquisition will advance Merck's ambition to provide a fully integrated and comprehensive solution for viral vector

Related Keywords

California , United States , Wisconsin , Canada , Dale Gordon , Mirus Bio , Matthias Heinzel , Merck Life Science Services , Serono , Merck Process Solutions , Gamma Biosciences , Business Wire , Executive Board , Process Solutions , Life Science Services , Ihr Portfolio ,